Compositions and methods for treating glioblastoma GBM

Details for Australian Patent Application No. 2011204407 (hide)

Owner Vascular Biogenics Ltd.

Inventors Cohen, Yael; Bangio, Livnat; Brenner, Andrew J.; Breitbart, Eyal

Agent Cullens

Pub. Number AU-A-2011204407

PCT Pub. Number WO2011/083466

Priority 61/282,248 07.01.10 US; 61/282,228 05.01.10 US

Filing date 5 January 2011

Wipo publication date 14 July 2011

International Classifications

C12N 15/00 Mutation or genetic engineering

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/083466 Priority application(s): WO2011/083466

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204422-Method of docking an autonomous robot

2011204406-Treatment with VB-201